AAAAAA
Results: 1-25/32
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Treatment of nonalcoholic fatty liver: Present and emerging therapies, SEM LIV DIS, 21(1), 2001, pp. 81-88
Authors:
Menon, KVN
Angulo, P
Weston, S
Dickson, ER
Lindor, KD
Citation: Kvn. Menon et al., Bone disease in primary biliary cirrhosis: independent indicators and rateof progression, J HEPATOL, 35(3), 2001, pp. 316-323
Authors:
Nehra, V
Angulo, P
Buchman, AL
Lindor, KD
Citation: V. Nehra et al., Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis, DIG DIS SCI, 46(11), 2001, pp. 2347-2352
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue, GASTROENTY, 120(5), 2001, pp. 1281-1285
Authors:
Abdelmalek, MF
Angulo, P
Jorgensen, RA
Sylvestre, PB
Lindor, KD
Citation: Mf. Abdelmalek et al., Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study, AM J GASTRO, 96(9), 2001, pp. 2711-2717
Authors:
Phillips, JR
Angulo, P
Petterson, T
Lindor, KD
Citation: Jr. Phillips et al., Fat-soluble vitamin levels in patients with primary biliary cirrhosis, AM J GASTRO, 96(9), 2001, pp. 2745-2750
Authors:
Harnois, DM
Angulo, P
Jorgensen, RA
LaRusso, NF
Lindor, KD
Citation: Dm. Harnois et al., High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis, AM J GASTRO, 96(5), 2001, pp. 1558-1562
Authors:
Menon, KVN
Angulo, P
Lindor, KD
Citation: Kvn. Menon et al., Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus, AM J GASTRO, 96(5), 2001, pp. 1631-1634
Authors:
Kaya, M
Petersen, BT
Angulo, P
Baron, TH
Andrews, JC
Gostout, CJ
Lindor, KD
Citation: M. Kaya et al., Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis, AM J GASTRO, 96(4), 2001, pp. 1059-1066
Authors:
Kaya, M
de Groen, PC
Angulo, P
Nagorney, DM
Gunderson, LL
Gores, GJ
Haddock, MG
Lindor, KD
Citation: M. Kaya et al., Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: The Mayo Clinic experience, AM J GASTRO, 96(4), 2001, pp. 1164-1169
Authors:
Angulo, P
Jorgensen, RA
Lindor, KD
Citation: P. Angulo et al., Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: Is a double dosage worthwhile?, AM J GASTRO, 96(11), 2001, pp. 3152-3157
Authors:
Angulo, P
El-Amin, O
Carpenter, HA
Lindor, KD
Citation: P. Angulo et al., Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis, AM J GASTRO, 96(10), 2001, pp. 3021-3027
Authors:
Angulo, P
Dickson, ER
Citation: P. Angulo et Er. Dickson, The timing of liver transplantation in primary biliary cirrhosis, BEST PR RES, 14(4), 2000, pp. 657-668
Authors:
Angulo, P
Patel, T
Jorgensen, RA
Therneau, TM
Lindor, KD
Citation: P. Angulo et al., Silymarin in the treatment of patients with primary biliary cirrhosis witha suboptimal response to ursodeoxycholic acid, HEPATOLOGY, 32(5), 2000, pp. 897-900
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Medical treatment for primary sclerosing cholangitis: Risk versus benefit, HEPATOLOGY, 32(4), 2000, pp. 871-872
Authors:
Angulo, P
Jorgensen, RA
Keach, JC
Dickson, ER
Smith, C
Lindor, KD
Citation: P. Angulo et al., Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid, HEPATOLOGY, 31(2), 2000, pp. 318-323
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Primary sclerosing cholangitis - Emerging new promising therapies, J CLIN GAST, 31(4), 2000, pp. 271-273
Authors:
Fong, DG
Angulo, P
Burgart, LJ
Lindor, KD
Citation: Dg. Fong et al., Cetirizine-induced cholestasis, J CLIN GAST, 31(3), 2000, pp. 250-253
Authors:
Angulo, P
Pearce, DH
Johnson, CD
Henry, JJ
LaRusso, NF
Petersen, BT
Lindor, KD
Citation: P. Angulo et al., Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis, J HEPATOL, 33(4), 2000, pp. 520-527
Authors:
Kaya, M
Angulo, P
Lindor, KD
Citation: M. Kaya et al., Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system, J HEPATOL, 33(4), 2000, pp. 537-542
Authors:
Angulo, P
Peter, JB
Gershwin, ME
DeSotel, CK
Shoenfeld, Y
Ahmed, AEE
Lindor, KD
Citation: P. Angulo et al., Serum autoantibodies in patients with primary sclerosing cholangitis, J HEPATOL, 32(2), 2000, pp. 182-187
Authors:
Angulo, P
Batts, KP
Jorgensen, RA
LaRusso, NA
Lindor, KD
Citation: P. Angulo et al., Oral budesonide in the treatment of primary sclerosing cholangitis, AM J GASTRO, 95(9), 2000, pp. 2333-2337
Authors:
Angulo, P
Keach, JC
Batts, KP
Lindor, KD
Citation: P. Angulo et al., Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, HEPATOLOGY, 30(6), 1999, pp. 1356-1362
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Primary sclerosing cholangitis, HEPATOLOGY, 30(1), 1999, pp. 325-332
Authors:
Angulo, P
Batts, KP
Therneau, TM
Jorgensen, RA
Dickson, ER
Lindor, KD
Citation: P. Angulo et al., Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 644-647